New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 13  •  04:00PM ET
26.74
Dollar change
-0.09
Percentage change
-0.34
%
IndexS&P 500 P/E- EPS (ttm)-7.52 Insider Own11.70% Shs Outstand389.00M Perf Week-2.90%
Market Cap10.44B Forward P/E- EPS next Y-7.46 Insider Trans-0.00% Shs Float344.88M Perf Month13.74%
Enterprise Value6.05B PEG- EPS next Q-2.08 Inst Own73.43% Short Float18.66% Perf Quarter-15.33%
Income-2.90B P/S3.39 EPS this Y-3.16% Inst Trans2.62% Short Ratio6.39 Perf Half Y2.06%
Sales3.08B P/B1.11 EPS next Y22.12% ROA-20.97% Short Interest64.34M Perf YTD-35.69%
Book/sh24.16 P/C2.04 EPS next 5Y19.26% ROE-27.50% 52W High59.73 -55.24% Perf Year-54.57%
Cash/sh13.14 P/FCF- EPS past 3/5Y- -42.94% ROIC-28.75% 52W Low23.15 15.51% Perf 3Y-78.63%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-43.99% 121.86% Gross Margin45.74% Volatility5.28% 5.17% Perf 5Y-62.36%
Dividend TTM- EV/Sales1.97 EPS Y/Y TTM51.07% Oper. Margin-106.34% ATR (14)1.36 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.77 Sales Y/Y TTM-38.95% Profit Margin-94.31% RSI (14)51.59 Recom2.89
Dividend Gr. 3/5Y- - Current Ratio3.93 EPS Q/Q36.16% SMA201.41% Beta2.01 Target Price43.42
Payout- Debt/Eq0.08 Sales Q/Q-41.08% SMA502.95% Rel Volume0.84 Prev Close26.83
Employees5800 LT Debt/Eq0.07 EarningsAug 01 BMO SMA200-10.83% Avg Volume10.07M Price26.74
IPODec 07, 2018 Option/ShortYes / Yes EPS/Sales Surpr.28.75% 28.16% Trades Volume9,187,262 Change-0.34%
Date Action Analyst Rating Change Price Target Change
Mar-13-25Initiated Citigroup Neutral $40
Feb-18-25Downgrade Barclays Overweight → Equal Weight $111 → $45
Jan-29-25Downgrade Goldman Buy → Neutral $99 → $51
Dec-18-24Downgrade Argus Buy → Hold
Dec-10-24Resumed BofA Securities Underperform $41
Nov-19-24Initiated Berenberg Hold $42
Nov-18-24Upgrade HSBC Securities Hold → Buy $58
Nov-15-24Initiated Wolfe Research Underperform $40
Oct-17-24Initiated Bernstein Mkt Perform $55
Sep-13-24Downgrade Oppenheimer Outperform → Perform
Oct-13-25 12:21PM
Oct-10-25 08:50AM
05:07AM
Oct-08-25 05:50PM
Oct-07-25 06:14AM
08:50AM Loading…
Oct-06-25 08:50AM
Oct-03-25 11:48AM
Oct-02-25 05:50PM
10:32AM
09:30AM
01:35AM
Oct-01-25 04:20PM
02:48PM
02:08PM
Sep-30-25 07:30AM
05:50PM Loading…
Sep-25-25 05:50PM
06:55AM
05:34AM
Sep-24-25 07:31PM
07:01PM
05:26PM
Sep-23-25 09:01PM
10:16AM
07:00AM
Sep-22-25 04:46PM
10:21AM
09:53AM
Sep-21-25 09:25AM
Sep-19-25 04:28PM
03:10PM
05:50PM Loading…
Sep-18-25 05:50PM
01:53PM
05:00AM
Sep-17-25 04:31PM
10:04AM
09:28AM
07:24AM
Sep-16-25 11:40AM
11:15AM
06:00AM
Sep-15-25 08:56AM
04:00AM
Sep-14-25 05:30AM
Sep-13-25 01:56PM
Sep-12-25 07:55PM
07:43PM
05:45PM
05:16PM
05:15PM
04:21PM
04:01PM
02:56PM
02:25PM
02:11PM
01:37PM
01:28PM
12:33PM
12:11PM
11:35AM
03:00AM
Sep-11-25 10:05AM
08:06AM
Sep-10-25 04:00AM
Sep-09-25 08:00PM
Sep-08-25 02:26PM
01:41PM
Sep-07-25 02:28PM
04:42AM
Sep-05-25 11:33AM
10:27AM
Sep-04-25 12:44AM
Sep-03-25 03:08PM
Sep-02-25 07:00AM
04:57AM
01:34AM
12:33AM
Aug-31-25 08:40AM
Aug-29-25 11:51AM
Aug-28-25 12:04PM
07:55AM
04:56AM
03:49AM
Aug-27-25 11:32PM
04:27PM
03:05PM
01:56PM
01:42PM
01:24PM
Aug-26-25 08:31PM
Aug-25-25 10:30AM
08:10AM
Aug-24-25 02:17AM
Aug-22-25 06:02PM
09:25AM
Aug-21-25 07:00AM
Aug-20-25 04:23PM
Aug-19-25 09:06AM
Aug-18-25 03:58AM
Aug-17-25 09:30AM
Aug-14-25 09:00AM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hussain AbbasDirectorJun 11 '25Sale28.003128,736580Jun 12 04:22 PM
Hussain AbbasDirectorJun 11 '25Proposed Sale28.003128,736Jun 11 10:06 AM
Bancel StephaneChief Executive OfficerMar 03 '25Buy31.22160,3145,004,3189,210,686Mar 04 04:27 PM
SAGAN PAULDirectorMar 03 '25Buy31.7631,6201,004,251312,027Mar 04 04:24 PM
Klinger Shannon ThymeChief Legal OfficerDec 09 '24Sale44.6852923,63720,446Dec 10 04:08 PM
Klinger Shannon ThymeOfficerDec 09 '24Proposed Sale44.6852923,637Dec 09 03:18 PM
Klinger Shannon ThymeChief Legal OfficerDec 03 '24Sale43.301124,84919,837Dec 04 05:11 PM
Hoge StephenPresidentDec 03 '24Sale43.3031413,5951,443,904Dec 04 05:08 PM
Klinger Shannon ThymeOfficerDec 03 '24Proposed Sale43.301124,849Dec 03 04:11 PM
Hoge StephenOfficerDec 03 '24Proposed Sale43.3031413,595Dec 03 03:23 PM
Mock James MChief Financial OfficerNov 29 '24Sale42.791,42060,76111,066Dec 02 04:26 PM
Klinger Shannon ThymeChief Legal OfficerNov 29 '24Sale42.791,41860,67519,717Dec 02 04:19 PM
Hoge StephenPresidentNov 29 '24Sale42.7929112,4521,443,567Dec 02 04:15 PM
Hoge StephenOfficerNov 29 '24Proposed Sale42.7929112,452Nov 29 03:54 PM
Klinger Shannon ThymeOfficerNov 29 '24Proposed Sale42.791,41860,675Nov 29 03:49 PM
Mock James MOfficerNov 29 '24Proposed Sale42.791,42060,761Nov 29 03:35 PM
Hoge StephenPresidentNov 11 '24Sale46.1027712,7711,443,248Nov 12 04:14 PM
Hoge StephenOfficerNov 11 '24Proposed Sale46.1027712,771Nov 12 09:27 AM